Article
Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based survey.
Leukemia & lymphoma - 1 Jun 2020
Pine Alexander B, Chokr Nora, Stahl Maximilian, Steensma David P, Sekeres Mikkael A, Litzow Mark R, Luger Selina M, Stone Richard M, Greenberg Peter L, Bejar Rafael, Bewersdorf Jan P, Gore Steven D, Zeidan Amer M
Abstract excerpt
Next-generation sequencing (NGS) is increasingly employed for diagnosis, risk stratification, and management of patients with myelodysplastic syndrome (MDS). We aimed to describe beliefs and practice patterns among providers who treat MDS patients with respect to the utility of NGS in diagnosis, risk stratification, prognosis, and treatment decisions at various points along the disease trajectory, response...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
